Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K E Sarji

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Thrombosis Research|December 1, 1975
Von Willebrand factor activity in normal subjects: sex difference and variabilityK E Sarji, J M Graves, J A Colwell
The Medical Clinics of North America|July 1, 1978
Platelet function and diabetes mellitusJ A Colwell, P V Halushka, K E Sarji, et al.
Advances in Experimental Medicine and Biology|January 1, 1978
Rationale for antiplatelet agents in diabetic vascular diseaseJ A Colwell, P V Halushka, K E Sarji, et al.
Thrombosis Research|February 1, 1977
Heparin-induced platelet aggregation in burn patientsJ A Mims, K E Sarji, J S Kleinfelder, et al.
Clinical Endocrinology|June 1, 1977
The effect of oral glucose on von Willebrand factor activity in normal and diabetic subjectsJ M Graves, J A Colwell, R M Nair, et al.
Research Communications in Chemical Pathology and Pharmacology|January 1, 1972
Platelet aggregometry in Hageman-deficients and in aspirin treated normal subjectsK E Sarji, P G Iatridis, N F Rodman, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1974
Nature of von Willebrand factor: a new assay and a specific inhibitorK E Sarji, R D Stratton, R H Wagner, et al.
Thrombosis Research|January 1, 1980
Effect of metabolic control with insulin on plasma von Willebrand factor activity (VIIIR:WF) in diabetes mellitusJ Gonzalez, J A Colwell, K E Sarji, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1977
Relation between growth hormone levels and Von Willebrand factor activityK E Sarji, J H Levine, R M Nair, et al.
Thrombosis Research|February 1, 1979
Abnormalities of platelet aggregation in sickle cell anemia. Presence of a plasma factor inhibiting aggregation by ristocetinK E Sarji, K Eurenius, C O Fullwood, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Thrombosis Research|December 1, 1975
Von Willebrand factor activity in normal subjects: sex difference and variabilityK E Sarji, J M Graves, J A Colwell
The Medical Clinics of North America|July 1, 1978
Platelet function and diabetes mellitusJ A Colwell, P V Halushka, K E Sarji, et al.
Advances in Experimental Medicine and Biology|January 1, 1978
Rationale for antiplatelet agents in diabetic vascular diseaseJ A Colwell, P V Halushka, K E Sarji, et al.
Thrombosis Research|February 1, 1977
Heparin-induced platelet aggregation in burn patientsJ A Mims, K E Sarji, J S Kleinfelder, et al.
Clinical Endocrinology|June 1, 1977
The effect of oral glucose on von Willebrand factor activity in normal and diabetic subjectsJ M Graves, J A Colwell, R M Nair, et al.
Research Communications in Chemical Pathology and Pharmacology|January 1, 1972
Platelet aggregometry in Hageman-deficients and in aspirin treated normal subjectsK E Sarji, P G Iatridis, N F Rodman, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1974
Nature of von Willebrand factor: a new assay and a specific inhibitorK E Sarji, R D Stratton, R H Wagner, et al.
Thrombosis Research|January 1, 1980
Effect of metabolic control with insulin on plasma von Willebrand factor activity (VIIIR:WF) in diabetes mellitusJ Gonzalez, J A Colwell, K E Sarji, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1977
Relation between growth hormone levels and Von Willebrand factor activityK E Sarji, J H Levine, R M Nair, et al.
Thrombosis Research|February 1, 1979
Abnormalities of platelet aggregation in sickle cell anemia. Presence of a plasma factor inhibiting aggregation by ristocetinK E Sarji, K Eurenius, C O Fullwood, et al.
Pageof 2